Sign Up Below To Receive More Information & Product Access
The Future of Regenerative Therapy Starts Here
Exosomes 3.0TM by Matrix Biologics
Exosomes 3.0 - The Next Generation Exosomes paired with AI Software.
Prioritizing safety, education, protocols and outcomes. We go where others can’t. Researching, validating, and bringing the most advanced regenerative products to the forefront of modern medicine.
We provide top-tier regenerative medicine products, complemented by our FDA-approved AI software, enabling providers to seamlessly and safely incorporate programs such as longevity, aesthetics, and pain management into their practice as turnkey solutions.
Our AI software enables providers to offer structured, customizable care menus, anchored in baseline patient data, predictive analytics, and clinically validated outcomes. Together, they support innovation, evidence‑based protocols, real‑world patient impact, and streamlined clinical implementation.
Matrix is committed to closing the gap between innovation and implementation. Delivering safe, high-performance, and research-backed healthcare solutions that empower providers and elevate patient care.
Market Categories We Serve Include:
Providers
Apply to become a Matrix Biologics Distributor
Only FDA-approved AI Software
Safest and most potent products on the market
Comprehensive education and resources
Expert Guidance and Ongoing support
Patients
Find out how Exosomes can help you with:
Performance Recovery (Pain)
Regenerative Aesthetics (Cosmetics)
Personalized Longevity Medicine
HOT OFF THE PRESS
PRESS RELEASE August 1, 2025
Matrix Biologics is proud to unveil Exosomes 3.0™ — the next evolution in regenerative biologics — enhanced by Integrated Safety Intelligence™ (ISI), a revolutionary new framework uniting clinical safety, FDA-aligned protocols, and business-ready infrastructure.
This milestone marks the official launch of the Matrix 3.0 Safety Intelligence Program, a comprehensive clinical and commercial training model designed to support responsible, profitable, and science-forward adoption of exosome therapy.
A New Era of Clinical Empowerment
Exosomes 3.0™ is not just a product — it’s a practice system. Built for the evolving needs of modern providers, it merges cellular innovation with real-world safety insights, personalized patient care workflows, and total regulatory confidence.
The Matrix 3.0 Safety Intelligence Program includes:
CME-Accredited Education
Hands-On Masterclasses
Virtual Interactive Certification
Modular Self-Paced Learning
Protocol & Compliance Toolkit
Patient Selection Criteria
Informed Consent & Risk Disclosures
FDA Regulatory Guidance
Quality Control Benchmarks
Integrated Business Engine
Reimbursement Strategy
Documentation Templates
Marketing & ROI Playbooks
This is the only platform that merges cutting-edge biologics with real-time safety metrics, clear FDA navigation, and turnkey business strategy.
Matrix Biologics continues to lead the field by combining precision biologics with real-world, scalable implementation frameworks. With Exosomes 3.0™, safety, innovation, and performance finally operate as a full-stack clinical ecosystem.
For media inquiries, email [email protected]
